ML

Misha D.P. Luyer

info

Please Note

1 records found

Journal article (2025) - Diederik W.M. Rasenberg, Mark Ramaekers, Alexander L. Vahrmeijer, Bert A. Bonsing, Erwin van der Harst, Marcel den Dulk, Ronald M. van Dam, Bas Groot Koerkamp, Joris I. Erdmann, Freek Daams, Olivier R. Busch, Igor Jacobs, Marc G. Besselink, Wouter W. te Riele, Rinze Reinhard, Frank Willem Jansen, Jenny Dankelman, J. Sven D. Mieog, Misha D.P. Luyer, Jon R. Pluyter, Luc J.F. Geurts, Bin Yu, John C.P. van der Ven, Joost Nederend, Ignace H.J.T. de Hingh
Background: Preoperative planning of patients diagnosed with pancreatic head cancer is difficult and requires specific expertise. This pilot study assesses the added value of three-dimensional (3D) patient models and computer-aided detection (CAD) algorithms in determining the resectability of pancreatic head tumors. Methods: This study included 14 hepatopancreatobiliary experts from eight hospitals. The participants assessed three radiologically resectable and three radiologically borderline resectable cases in a simulated setting via crossover design. Groups were divided in controls (using a CT scan), a 3D group (using a CT scan and 3D models), and a CAD group (using a CT scan, 3D and CAD). For the perceived fulfillment of preoperative needs, the quality and confidence of clinical decision-making were evaluated. Results: A higher perceived ability to determine degrees and the length of tumor–vessel contact was reported in the CAD group compared to controls (p = 0.022 and p = 0.003, respectively). Lower degrees of tumor–vessel contact were predicted for radiologically borderline resectable tumors in the CAD group compared to controls (p = 0.037). Higher confidence levels were observed in predicting the need for vascular resection in the 3D group compared to controls (p = 0.033) for all cases combined. Conclusions: “CAD (including 3D) improved experts’ perceived ability to accurately assess vessel involvement and supports the development of evolving techniques that may enhance the diagnosis and treatment of pancreatic cancer”. ...